Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06690840 |
| Title | Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients (AZALEA) |
| Acronym | AZALEA |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | European Institute of Oncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Azienda Sanitaria Locale Br | Brindisi | Italy | Details | |||
| European Institute of Oncology | Milan | 20141 | Italy | Details | ||
| Fondazione IRCCS San Gerardo Dei Tintori | Monza | 20900 | Italy | Details | ||
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Roma | 00168 | Italy | Details | ||
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Roma | 00168 | Italy | Details |